Skip navigation
Please use this identifier to cite or link to this item: https://mnclhd.intersearch.com.au/mnclhdjspui/handle/123456789/182
Full metadata record
DC FieldValueLanguage
dc.contributor.authorBegbie, S.-
dc.contributor.authorBurgess, K. R.-
dc.date.accessioned2024-12-03T02:26:02Z-
dc.date.available2024-12-03T02:26:02Z-
dc.date.issued1993-01-
dc.identifier.citationChest . 1993 Jan;103(1):305-6. doi: 10.1378/chest.103.1.305.en
dc.identifier.urihttps://mnclhd.intersearch.com.au/mnclhdjspui/handle/123456789/182-
dc.description.abstractA 47-year-old woman developed pulmonary eosinophilia from the use of maloprim as malaria prophylaxis. The diagnosis was confirmed by bronchoalveolar lavage (BAL) and transbronchial lung biopsy. Her condition improved with drug withdrawal and steroid therapy. With the increased use of pyrimethamine and dapsone in the treatment of human immunodeficiency syndrome (HIV) infection, this form of drug allergy may become more common.en
dc.language.isoenen
dc.subjectPulmonary Eosinophiliaen
dc.subjectMaloprimen
dc.subjectBronchoalveolar Lavageen
dc.subjectHIV Infectionsen
dc.subjectMalariaen
dc.titleMaloprim-induced pulmonary eosinophiliaen
dc.typeArticleen
dc.contributor.mnclhdauthorBegbie, Stephen-
Appears in Collections:Medicine

Files in This Item:
There are no files associated with this item.


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.

Google Media

Google ScholarTM

Who's citing